Lineage Cell Therapeutics Inc (LCTX)

[terry hallinan]

DeepDive,

The near term value generating news will have to do with commercialization of Renevia: Distribution in the EU, commercial terms, Orders, etc. They have not PRed getting it yet, though.

BioTime Submits CE Mark Application for European Approval of Renevia®

“We look forward to approval in the EU and, provided appropriate clinical data support, expanding the label into other indications and geographies, including the U.S.”

BioTime views the European pivotal trial in HIV-associated lipoatrophy as an entryway into a larger market opportunity, like cosmetic facial aesthetics.

https://www.businesswire.com/news/home/20180313005625/en/BioTime-Submits-CE-Mark-Application-European-Approval

Yeah OK, that will be great news but a CE mark is a kind of license to further explore a new technology rather than full commercialization.

Initial trials were in AIDS victims. The trials were pseudo-medical trials providing some cosmetic relief from the ravages of a terrible disease.

I guess aging can be looked at in the same way as disease but naturally many will want something more than nature's normal bounty.

Trials started in the U.S. are purely cosmetic.

That's where the big money really is.

Again the CE mark approval will be great news but it may be a while before Renevia strikes real pay dirt.

I am not sure BTX will not be able to quickly transition Renevia away from a medical procedure to a strictly beauty treatment though that is clearly the aim. I could imagine beauty treatments in America long before there is any FDA approval but have no idea if that is possible.

Best, Terry